[1]
Bitsianis, S. et al. 2022. The feasibility and effect of intraperitoneal administration of regorafenib on peritoneal carcinomatosis from colorectal cancer in the rat. Annali Italiani di Chirurgia. 93, 5 (Sep. 2022), 592–598.